Kinnevik
Kinnevik is a leading growth investor on a mission to redefine industries and create remarkable growth companies. We are an active owner and operational partner, providing patient capital to challenger technology-enabled businesses in Europe and the US. Our passionate founders are building tomorrow’s leaders within healthcare, software and climate,
Investment focus
Kinnevik's portfolio on More Capital spans healthcare & biotech, fintech, enterprise software. The firm is based in Stockholm, Skåne County, Sweden. Of the 7 portfolio companies tracked here, 7 have publicly reported valuations totaling approximately $22B.
If your company is backed by Kinnevik
Employees at companies backed by Kinnevik may encounter this fund's name on their cap table, in board communications, or in funding announcements. Understanding who invests in your employer can provide useful context when evaluating your equity.
What this means for your stock
Institutional investors like Kinnevik typically hold preferred shares with rights that differ from the common stock or options held by employees. In a liquidity event, preferred shareholders may have liquidation preferences, anti-dilution protections, or board-level governance rights that affect the value of common equity. The specific terms depend on each company's funding agreements.
Secondary market considerations
Some venture-backed companies allow employees to sell shares on secondary markets, while others restrict transfers. Whether your company permits secondary sales, and under what conditions, is typically governed by the company's equity plan and any applicable right-of-first-refusal provisions — not by the fund itself. However, the presence of institutional investors can sometimes signal the maturity and governance structure of the company.
Kinnevik portfolio companies
7 companies tracked on More Capital, sorted by reported valuation.
Top holdings by valuation
By sector
Industries invested in
Frequent co-investors
Funds that most frequently co-invest alongside Kinnevik in the same companies.
Last verified: 2026-05-28
Portfolio data compiled from public filings, press releases, and industry databases. Valuations are reported figures and may not reflect current market conditions. Not investment advice. Consult a qualified advisor before making financial decisions.